MAPAP is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Direct_rx. The primary component is Acetaminophen.
Product ID | 61919-857_8eebe866-0abb-79c0-e053-2a95a90a8837 |
NDC | 61919-857 |
Product Type | Human Otc Drug |
Proprietary Name | MAPAP |
Generic Name | Mapap |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2019-07-30 |
Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
Application Number | part343 |
Labeler Name | Direct_Rx |
Substance Name | ACETAMINOPHEN |
Active Ingredient Strength | 325 mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-07-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph not final |
Application Number | part343 |
Product Type | HUMAN OTC DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-07-30 |
Ingredient | Strength |
---|---|
ACETAMINOPHEN | 325 mg/1 |
SPL SET ID: | 8eebe866-0aba-79c0-e053-2a95a90a8837 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0904-1982 | Mapap | ACETAMINOPHEN |
0904-1987 | MAPAP | Acetaminophen |
0904-5751 | Mapap | Acetaminophen |
0904-5816 | Mapap | Acetaminophen |
0904-6536 | Mapap | Acetaminophen |
33261-142 | Mapap | ACETAMINOPHEN |
49999-131 | Mapap | ACETAMINOPHEN |
50090-0266 | Mapap | ACETAMINOPHEN |
50090-2907 | Mapap | ACETAMINOPHEN |
50436-3220 | Mapap | ACETAMINOPHEN |
53808-0822 | MAPAP | Acetaminophen |
55154-1325 | Mapap | Acetaminophen |
60760-935 | Mapap | ACETAMINOPHEN |
61919-857 | MAPAP | MAPAP |
61919-875 | MAPAP | MAPAP |
63629-6344 | Mapap | ACETAMINOPHEN |
70518-0470 | Mapap | ACETAMINOPHEN |
70518-1292 | Mapap | ACETAMINOPHEN |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
MAPAP 76126557 2490633 Live/Registered |
Harvard Drug Group, LLC, The 2000-09-12 |
MAPAP 74215554 1732421 Dead/Cancelled |
MAJOR PHARMACEUTICAL CORPORATION 1991-10-23 |